EISSN 2684-4907

5 YEAR IMPACT FACTOR 0.2 SCOPUS CITESCORE 0.6 IMPACT FACTOR 0.2

B-ENT

20 109 2024

HIGHLY CITED ARTICLES

COVID-19 and olfactory dysfunction - an ENT perspective to the current COVID-19 pandemic

By: Vroegop, AV; Eeckels, AS; Van Rompaey, V; et al.

Prioritizing otological surgery during the COVID-19 pandemic

By: Topsakal, V; Van Rompaey, V; Kuhweide, R; et al.

Tracheostomy and personal protective equipment (PPE) in the midst of the COVID-19 pandemic

By: Faris, C; Deben, K; Van Haesendonck, G; et al.

Anosmia and COVID-19 in south Lombardy: description of the first cases series in Europe

By: Capelli, M and Gatti, P

Evaluation of nasal function in patients with COVID-19: nasal secretion, nasal clearance, and SNOT-22 score

By: Baki, A; Damlaca, S; Yildiz, M; et al.

Challenges in pediatric otolaryngology in the COVID-19 pandemic: insights from current protocols and management strategies

By: Van der Poel, N; Mansbach, AL; Loundon, N; et al.

Minimal outcome measurements in pediatric cochlear implant users: a consensus paper

By: Mertens, G; Hofkens, A; Van de Heyning, P; et al.

Is an increase in the depth of the olfactory fossa caused by excessive vertical facial growth? A radiological study ocr

By: Calvo-Henriquez, C; Ruano-Ravina, A; Martinez-Capoccioni, G; et al.

Vagus nerve stimulation therapy induces laryngopharyngeal reflux: a preliminary evaluation

G. A. Marciante ¹ , G. Felisati ¹ , C. Pipolo ¹ , A. Maccari ¹ , M. P. Canevini ² , M. De Gasperis ¹ , E. Zambrelli ² , A. Vignoli ² , F. Furia ² , A. M. Saibene ¹

Author Affiliation(s)

1.

Otolaryngology Unit, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Via Antonio di Rudinì, 20142 Milan, Italy

2.

Regional Centre for Epilepsy, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Via Antonio di Rudinì, 20142 Milan, Italy

B-ENT 2017; 13: 275-279

Keywords : Drug resistant epilepsy, endoscopic reflux evaluation, reflux symptom index, reflux findings score

Read: 755 Downloads: 427 Published: 01 February 2020

Volume 13, Issue 4, December 2017

Previous Article

Vagus nerve stimulation therapy induces laryngopharyngeal reflux: a preliminary evaluation. Objective: Vagus Nerve Stimulation (VNS) is an approved therapy for drug- and surgery-resistant epilepsy. Despite the vagal role in regulating gastric secretion, there are no reports focusing on the prevalence of laryngopharyngeal reflux (LPR) in the VNS-implanted population. Our study aims to evaluate the prevalence of the disease in VNS-implanted patients.

Methods: All patients underwent endoscopic Otolaryngological reflux assessment based on the reflux finding score (RFS) and contextual self-assessment of symptoms by means of reflux symptom index (RSI) questionnaire.

Results: While only 3 out of 16 patients experienced symptomatic LPR (RSI>13), endoscopy documented LPR (RFS>7) in 12 out of 16 patients, there was no correlation between RSI and RFS (p.617). There has been an important trend between LPR findings since implantation was observed (p. 103).

Conclusions: LPR has a significant prevalence in VNS-implanted patients. A routine Otolaryngological follow-up could allow the prompt diagnosis and treatment of LPR in this population.

Files